Shinbaro

also known as GCSB-5

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Comparator or background therapy1 trial
Phase 2/3	NCT01910116 Comparator	Sep 2013 → Nov 2014	osteoarthritis, hand	Seoul National University Hospital	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Shinbaro	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01910116 ↗
Known as	GCSB-5	“After randomization, patients were allocated to receive oral GCSB-5 600 mg or placebo, bid for 12 weeks.” PMID 27449412 ↗ Jul 2016
Modality	Traditional medicine (herbal / TCM)	“GCSB-5 (Shinbaro) is a mixture of six purified oriental herb extracts in a fixed ratio” NCT01910116 ↗
Route	Oral	“patients were allocated to receive oral GCSB-5 600 mg or placebo” PMID 27449412 ↗ Jul 2016